The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A prospective multi-site translational study investigating the association of gut microbiome (GM) diversity with pathological complete response (pCR) after neoadjuvant treatment in early stage rectal and esophageal cancer.
 
Rachel Clarke
Travel, Accommodations, Expenses - Ipsen
 
Ronan McLaughlin
Honoraria - Merck
Travel, Accommodations, Expenses - MSD; Pfizer; Takeda
 
Christopher Cronin
No Relationships to Disclose
 
Ruth Kieran
No Relationships to Disclose
 
Ciaran Devoy
No Relationships to Disclose
 
Carolyn Moloney
No Relationships to Disclose
 
Orla Fitzpatrick
No Relationships to Disclose
 
David O'Reilly
No Relationships to Disclose
 
Conor Moloney
No Relationships to Disclose
 
Maciej Milewski
No Relationships to Disclose
 
Kathleen Bennett
Research Funding - Novartis
 
Megan Greally
No Relationships to Disclose
 
Adrian Murphy
No Relationships to Disclose
 
Jarushka Naidoo
Honoraria - Abbvie/Genentech; Amgen; Arcus Biosciences; AstraZeneca/MedImmune; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Daiichi Sankyo/Lilly; Elevation Oncology; Kaleido Biosciences; Merck; Mirati Therapeutics; NGM Biopharmaceuticals; Pfizer; Regeneron; Roche/Genentech; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Arcus Biosciences; AstraZeneca/MedImmune; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Elevation Oncology; Kaleido Biosciences; Merck; Merck KGaA; Mirati Therapeutics; NGM Biopharmaceuticals; Pfizer; Regeneron; Roche/Genentech; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb; Pfizer
 
Patrick Morris
No Relationships to Disclose
 
Oscar Breathnach
No Relationships to Disclose
 
William Grogan
No Relationships to Disclose
 
Sinead Toomey
No Relationships to Disclose
 
Mark Tangney
No Relationships to Disclose
 
Bryan Hennessy
No Relationships to Disclose